Authors: Wedderburn, LR Jeffery, R White, H Patel, A Varsani, H Linch, D Murray, K Woo, P

Citation: Lr. Wedderburn et al., Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO(+) to RA(+) phenotype, RHEUMATOLOG, 40(11), 2001, pp. 1299-1307

Authors: Linch, D

Citation: D. Linch, Current treatment of follicular and low-grade non-Hodgkin's lymphoma, ANTI-CANC D, 12, 2001, pp. S5-S9

Authors: Mainwaring, PN Cunningham, D Gregory, W Hoskin, P Hancock, B Norton, AJ MacLennan, K Smith, P Hudson, GV Linch, D

Citation: Pn. Mainwaring et al., Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen forpatients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdfiaCEBO versus PMitCEBO, BLOOD, 97(10), 2001, pp. 2991-2997

Authors: Bhidayasira, R Linch, D

Citation: R. Bhidayasira et D. Linch, High dose therapy for Hodgkin's disease, BLOOD REV, 13(1), 1999, pp. 45-50

Authors: Gari, M Goodeve, A Wilson, G Winship, P Langabeer, S Linch, D Vandenberghe, E Peake, I Reilly, J

Citation: M. Gari et al., c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia, BR J HAEM, 105(4), 1999, pp. 894-900

Authors: Allford, S Grimwade, D Langabeer, S Duprez, E Saurin, A Chatters, S Walker, H Roberts, P Rogers, J Bain, B Patterson, K McKernan, A Freemont, P Solomon, E Burnett, A Goldstone, A Linch, D

Citation: S. Allford et al., Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RAR alpha rearrangement in newly diagnosed AML, BR J HAEM, 105(1), 1999, pp. 198-207